Expression of Com‐1/P8 in human breast cancer and its relevance to clinical outcome and ER status
暂无分享,去创建一个
G. Watkins | R. Mansel | W. Jiang | A. Douglas-Jones | O. Fodstad | K. Mokbel | Robert E Mansel | W. Jiang
[1] W. Jiang,et al. Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection. , 2005, Biochemical and biophysical research communications.
[2] G. Watkins,et al. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.
[3] Troy Stevens,et al. Open Access Activated Leukocyte Cell Adhesion Molecule in Breast Cancer: Prognostic Indicator , 2022 .
[4] J. Hartman,et al. Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D , 2004 .
[5] G. Firestone,et al. Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest , 2004, Cancer Research.
[6] J. Hartman,et al. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Watkins,et al. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] A. Miyauchi,et al. Expression and cellular localization of p8 protein in thyroid neoplasms. , 2003, Cancer letters.
[9] J. Iovanna,et al. Research p 8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth , 2016 .
[10] R. Mansel,et al. Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003 .
[11] R. Feil,et al. p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis , 2002, Oncogene.
[12] J. Dagorn,et al. p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene , 2002, EMBO reports.
[13] J. Iovanna,et al. Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] J. Iovanna,et al. Expression of p8 in human pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] C. Hansen,et al. Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells. , 2000, Cancer research.
[16] M. Brentani,et al. Expression of a novel factor, com1, in early tumor progression of breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] W. Jiang,et al. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. , 2000, The Journal of urology.
[18] J. Iovanna,et al. Cloning and expression of the human p8, a nuclear protein with mitogenic activity. , 2001, European journal of biochemistry.
[19] E. Hovig,et al. Expression of a novel factor in human breast cancer cells with metastatic potential. , 1999, Cancer research.
[20] J. Iovanna,et al. Cloning and Expression of the Rat p8 cDNA, a New Gene Activated in Pancreas during the Acute Phase of Pancreatitis, Pancreatic Development, and Regeneration, and Which Promotes Cellular Growth* , 1997, The Journal of Biological Chemistry.
[21] I. Nazarenko,et al. A closed tube format for amplification and detection of DNA based on energy transfer. , 1997, Nucleic acids research.
[22] F. Sigaux,et al. The MTCP-1/c6.1B gene encodes for a cytoplasmic 8 kD protein overexpressed in T cell leukemia bearing a t(X;14) translocation. , 1994, Oncogene.